NCT03904446View on ClinicalTrials.gov

Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 8, 2019

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Uterine Atony With Hemorrhage
Interventions
DRUG

Methylergonovine

0.2 mg of intramuscular methylergonovine at the time of cesarean section following standard IV oxytocin infusion.

DRUG

Normal Saline (placebo)

1 ml of normal saline intramuscular at the time of cesarean section following standard IV oxytocin infusion

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Cynthia Wong

OTHER

NCT03904446 - Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients | Biotech Hunter | Biotech Hunter